These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24635877)

  • 1. Acquired immunogenicity of DNA after modification with malondialdehyde in patients with alopecia areata.
    Alzolibani AA; Rasheed Z; Al Robaee AA
    Scand J Clin Lab Invest; 2014 Jun; 74(4):312-21. PubMed ID: 24635877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and immunological studies on erythrocytes superoxide dismutase modified by nitric oxide in patients with alopecia areata: Implications in alopecia patchy persistent and alopecia universalis.
    Rasheed Z; Alzolibani AA; Al-Shobaili HA; Saif GB; Al Robaee AA
    Immunol Lett; 2014 Jul; 160(1):50-57. PubMed ID: 24694751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of lipid peroxidation, oxidant/antioxidant status, and serum nitric oxide levels in alopecia areata.
    Koca R; Armutcu F; Altinyazar C; Gürel A
    Med Sci Monit; 2005 Jun; 11(6):CR296-299. PubMed ID: 15917721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
    Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
    Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against malondialdehyde (MDA) in MRL/lpr/lpr mice: evidence for an autoimmune mechanism involving lipid peroxidation.
    Yahya MD; Pinnas JL; Meinke GC; Lung CC
    J Autoimmun; 1996 Feb; 9(1):3-9. PubMed ID: 8845052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphenol A modified DNA: A possible immunogenic stimulus for anti-DNA autoantibodies in systemic lupus erythematosus.
    Alhomaidan HT; Rasheed N; Almatrafi S; Al-Rashdi FH; Rasheed Z
    Autoimmunity; 2019; 52(7-8):272-280. PubMed ID: 31656085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress in alopecia areata: a case-control study.
    Bakry OA; Elshazly RM; Shoeib MA; Gooda A
    Am J Clin Dermatol; 2014 Feb; 15(1):57-64. PubMed ID: 23839259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitopes, avidity and IgG subclasses of tyrosine hydroxylase autoantibodies in vitiligo and alopecia areata patients.
    Rahoma SF; Sandhu HK; McDonagh AJ; Gawkrodger DJ; Weetman AP; Kemp EH
    Br J Dermatol; 2012 Jul; 167(1):17-28. PubMed ID: 22329856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protective role of the HLA-DR locus in patients with various clinical types of alopecia areata.
    Broniarczyk-Dyła G; Prusińska-Bratoś M; Dubla-Berner M; Arkuszewska C; Borowiec M; Kowalski ML; Woszczek G
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):333-6. PubMed ID: 12455867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients.
    Okamoto M; Ogawa Y; Watanabe A; Sugiura K; Shimomura Y; Aoki N; Nagasaka T; Tomita Y; Muro Y
    J Autoimmun; 2004 Nov; 23(3):257-66. PubMed ID: 15501396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population.
    Kalkan G; Karakus N; Baş Y; Takçı Z; Ozuğuz P; Ateş O; Yigit S
    Gene; 2013 Sep; 527(2):565-9. PubMed ID: 23831512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata.
    Zhao M; Liang G; Wu X; Wang S; Zhang P; Su Y; Yin H; Tan Y; Zhang J; Lu Q
    Br J Dermatol; 2012 Feb; 166(2):226-73. PubMed ID: 21936853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyl radical damaged immunoglobulin G in patients with rheumatoid arthritis: biochemical and immunological studies.
    Rasheed Z
    Clin Biochem; 2008 Jun; 41(9):663-9. PubMed ID: 18359293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase C677T mutation in patients with alopecia areata in Turkish population.
    Kalkan G; Yigit S; Karakuş N; Ateş O; Bozkurt N; Ozdemir A; Pancar GŞ
    Gene; 2013 Nov; 530(1):109-12. PubMed ID: 23954881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential recognition of hydroxyl radical-modified superoxide dismutase by circulating autoantibodies in patients with alopecia areata.
    Alzolibani AA
    Ann Dermatol; 2014 Oct; 26(5):576-83. PubMed ID: 25324649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of autoimmune regulator haplotypes in alopecia areata.
    Wengraf DA; McDonagh AJ; Lovewell TR; Vasilopoulos Y; Macdonald-Hull SP; Cork MJ; Messenger AG; Tazi-Ahnini R
    Tissue Antigens; 2008 Mar; 71(3):206-12. PubMed ID: 18194361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early stage alopecia areata is associated with inflammation in the upper dermis and damage to the hair follicle infundibulum.
    Zhang B; Zhao Y; Cai Z; Caulloo S; McElwee KJ; Li Y; Chen X; Yu M; Yang J; Chen W; Tang X; Zhang X
    Australas J Dermatol; 2013 Aug; 54(3):184-91. PubMed ID: 23808570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alopecia areata during anti-TNF alpha therapy: Nine cases].
    Le Bidre E; Chaby G; Martin L; Perrussel M; Sassolas B; Sigal ML; Kaassis C; Lespessailles E; Nseir A; Estève E
    Ann Dermatol Venereol; 2011; 138(4):285-93. PubMed ID: 21497255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of cell-mediated immune response in pathogenesis of alopecia areata].
    Lis A; Pierzchała E; Brzezińska-Wcisło L
    Wiad Lek; 2001; 54(3-4):159-63. PubMed ID: 11436681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alopecia areata and autoimmunity.
    Grandolfo M; Biscazzi AM; Pipoli M
    G Ital Dermatol Venereol; 2008 Oct; 143(5):277-81. PubMed ID: 18833068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.